TORONTO, ONTARIO--(Marketwired - Oct. 31, 2014) - The common shares of BioMark Diagnostics Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at thecse.com.
Trading Date: November 3, 2014 |
Symbol: BUX |
CUSIP: 09073K 10 8 |
ISIN: CA 09073K 10 8 4 |
Boardlot: 500 |
If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.
Contact Information:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com